The risk of colon cancer can be reduced by using daily insulin

People at risk of gastrointestinal cancer may reduce their risk by relying on a daily dose of insulin, a new study suggests.

People who regularly use painkillers can significantly reduce the risk of bowel cancer, information found from a study involving more than 600,000 people.

Patients who were prescribed aspirin daily showed a 47% reduction in the rate of liver cancer and esophageal cancer.

Stomach cancer decreased by 38%, pancreatic cancer decreased by 34%, while colorectal cancer decreased by 24%.

Gastrointestinal cancer, although not widespread, is still fatal to many people globally.

Colorectal, stomach and pancreatic cancers are among the top 5 cancer killers in the world, with gastrointestinal cancer accounting for 30.1% of cancer deaths.

The effectiveness of long-term long-term use of aspirin is also found to significantly reduce leukemia, lung cancer and prostate cancer and some cancers of the breast, bladder, kidney and multiple myeloma.

While the use of aspirin is still discussed in the medical community, a recent study also found that patients who stopped taking aspirin had a 37% increased risk of cardiovascular disease, such as heart attack or stroke .